The Lysosomal Protein Saposin B Binds Chloroquine

Brian P. Huta, Matthew R. Mehlenbacher, Yan Nie, Xuelei Lai, Chloe Zubieta, Fadi Bou-Abdallah, Robert Patrick Doyle

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Chloroquine (CQ) has been widely used in the treatment of malaria since the 1950s, though toxicity and resistance is increasingly limiting its use in the clinic. More recently, CQ is also becoming recognized as an important therapeutic compound for the treatment of autoimmune disorders and has shown activity as an anticancer agent. However, the full extent of CQ pharmacology in humans is still unclear. Herein, we demonstrate that the lysosomal protein saposin B (sapB), critical for select lipid degradation, binds CQ with implications for both CQ function and toxicity. Using isothermal titration calorimetry (ITC) and fluorescence quenching experiments, CQ was shown to bind to the dimeric form of sapB at both pH 5.5 and pH 7.4 with an average binding affinity of 2.3×104 m-1. X-ray crystallography confirmed this, and the first complete crystal structure of sapB with a bound small molecule (CQ) is reported. The results suggest that sapB might play a role in mitigating CQ-based toxicity and that sapB might itself be overwhelmed by CQ causing impaired lipid degradation.

Original languageEnglish (US)
Pages (from-to)277-282
Number of pages6
JournalChemMedChem
Volume11
Issue number3
DOIs
StatePublished - Feb 4 2016

Fingerprint

Saposins
Chloroquine
Toxicity
Lipids
lysosomal proteins
IgA receptor
Degradation
Calorimetry
X ray crystallography
X Ray Crystallography
Titration
Antineoplastic Agents
Malaria
Quenching
Crystal structure
Fluorescence

Keywords

  • chloroquine
  • isothermal titration calorimetry
  • lysosomes
  • malaria
  • protein crystal structures
  • saposin B

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine

Cite this

Huta, B. P., Mehlenbacher, M. R., Nie, Y., Lai, X., Zubieta, C., Bou-Abdallah, F., & Doyle, R. P. (2016). The Lysosomal Protein Saposin B Binds Chloroquine. ChemMedChem, 11(3), 277-282. https://doi.org/10.1002/cmdc.201500494

The Lysosomal Protein Saposin B Binds Chloroquine. / Huta, Brian P.; Mehlenbacher, Matthew R.; Nie, Yan; Lai, Xuelei; Zubieta, Chloe; Bou-Abdallah, Fadi; Doyle, Robert Patrick.

In: ChemMedChem, Vol. 11, No. 3, 04.02.2016, p. 277-282.

Research output: Contribution to journalArticle

Huta, BP, Mehlenbacher, MR, Nie, Y, Lai, X, Zubieta, C, Bou-Abdallah, F & Doyle, RP 2016, 'The Lysosomal Protein Saposin B Binds Chloroquine', ChemMedChem, vol. 11, no. 3, pp. 277-282. https://doi.org/10.1002/cmdc.201500494
Huta BP, Mehlenbacher MR, Nie Y, Lai X, Zubieta C, Bou-Abdallah F et al. The Lysosomal Protein Saposin B Binds Chloroquine. ChemMedChem. 2016 Feb 4;11(3):277-282. https://doi.org/10.1002/cmdc.201500494
Huta, Brian P. ; Mehlenbacher, Matthew R. ; Nie, Yan ; Lai, Xuelei ; Zubieta, Chloe ; Bou-Abdallah, Fadi ; Doyle, Robert Patrick. / The Lysosomal Protein Saposin B Binds Chloroquine. In: ChemMedChem. 2016 ; Vol. 11, No. 3. pp. 277-282.
@article{ffff36ac8afb46868fa9c6200cd57ce4,
title = "The Lysosomal Protein Saposin B Binds Chloroquine",
abstract = "Chloroquine (CQ) has been widely used in the treatment of malaria since the 1950s, though toxicity and resistance is increasingly limiting its use in the clinic. More recently, CQ is also becoming recognized as an important therapeutic compound for the treatment of autoimmune disorders and has shown activity as an anticancer agent. However, the full extent of CQ pharmacology in humans is still unclear. Herein, we demonstrate that the lysosomal protein saposin B (sapB), critical for select lipid degradation, binds CQ with implications for both CQ function and toxicity. Using isothermal titration calorimetry (ITC) and fluorescence quenching experiments, CQ was shown to bind to the dimeric form of sapB at both pH 5.5 and pH 7.4 with an average binding affinity of 2.3×104 m-1. X-ray crystallography confirmed this, and the first complete crystal structure of sapB with a bound small molecule (CQ) is reported. The results suggest that sapB might play a role in mitigating CQ-based toxicity and that sapB might itself be overwhelmed by CQ causing impaired lipid degradation.",
keywords = "chloroquine, isothermal titration calorimetry, lysosomes, malaria, protein crystal structures, saposin B",
author = "Huta, {Brian P.} and Mehlenbacher, {Matthew R.} and Yan Nie and Xuelei Lai and Chloe Zubieta and Fadi Bou-Abdallah and Doyle, {Robert Patrick}",
year = "2016",
month = "2",
day = "4",
doi = "10.1002/cmdc.201500494",
language = "English (US)",
volume = "11",
pages = "277--282",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - The Lysosomal Protein Saposin B Binds Chloroquine

AU - Huta, Brian P.

AU - Mehlenbacher, Matthew R.

AU - Nie, Yan

AU - Lai, Xuelei

AU - Zubieta, Chloe

AU - Bou-Abdallah, Fadi

AU - Doyle, Robert Patrick

PY - 2016/2/4

Y1 - 2016/2/4

N2 - Chloroquine (CQ) has been widely used in the treatment of malaria since the 1950s, though toxicity and resistance is increasingly limiting its use in the clinic. More recently, CQ is also becoming recognized as an important therapeutic compound for the treatment of autoimmune disorders and has shown activity as an anticancer agent. However, the full extent of CQ pharmacology in humans is still unclear. Herein, we demonstrate that the lysosomal protein saposin B (sapB), critical for select lipid degradation, binds CQ with implications for both CQ function and toxicity. Using isothermal titration calorimetry (ITC) and fluorescence quenching experiments, CQ was shown to bind to the dimeric form of sapB at both pH 5.5 and pH 7.4 with an average binding affinity of 2.3×104 m-1. X-ray crystallography confirmed this, and the first complete crystal structure of sapB with a bound small molecule (CQ) is reported. The results suggest that sapB might play a role in mitigating CQ-based toxicity and that sapB might itself be overwhelmed by CQ causing impaired lipid degradation.

AB - Chloroquine (CQ) has been widely used in the treatment of malaria since the 1950s, though toxicity and resistance is increasingly limiting its use in the clinic. More recently, CQ is also becoming recognized as an important therapeutic compound for the treatment of autoimmune disorders and has shown activity as an anticancer agent. However, the full extent of CQ pharmacology in humans is still unclear. Herein, we demonstrate that the lysosomal protein saposin B (sapB), critical for select lipid degradation, binds CQ with implications for both CQ function and toxicity. Using isothermal titration calorimetry (ITC) and fluorescence quenching experiments, CQ was shown to bind to the dimeric form of sapB at both pH 5.5 and pH 7.4 with an average binding affinity of 2.3×104 m-1. X-ray crystallography confirmed this, and the first complete crystal structure of sapB with a bound small molecule (CQ) is reported. The results suggest that sapB might play a role in mitigating CQ-based toxicity and that sapB might itself be overwhelmed by CQ causing impaired lipid degradation.

KW - chloroquine

KW - isothermal titration calorimetry

KW - lysosomes

KW - malaria

KW - protein crystal structures

KW - saposin B

UR - http://www.scopus.com/inward/record.url?scp=84957599134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957599134&partnerID=8YFLogxK

U2 - 10.1002/cmdc.201500494

DO - 10.1002/cmdc.201500494

M3 - Article

C2 - 26616259

AN - SCOPUS:84957599134

VL - 11

SP - 277

EP - 282

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 3

ER -